Cassanello G, Drill E, Rivas-Delgado A, Okwali M, et al. Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience. Haematologica 2024 Sep 5. doi: 10.3324/haematol.2024.285600.
PMID: 39234863